The Impact of Genomics on Public Health Practice: The Case for ChangeZimmern R.L. · Khoury M.J.
aFoundation for Genomics and Population Health, Cambridge, UK; bDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Md., and cOffice of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Ga., USA
Public health practice will not be able in the 21st century to ignore the impact of genomics, cell and molecular biology. It will need to take into consideration issues that include, among others: the complementary nature of social and biological models of disease, genetic exceptionalism, the readiness of public and patient to respond to genomic information, the relationship between individuals and populations, and concepts of population stratification. Health systems will need to adapt their practice and organisation to include new sequencing technologies, bioinformatic expertise and proper evaluation of genetic and molecular tests. Links with the commercial sector will increase in importance. The impact on developing countries cannot be ignored and will require special attention.
Ronald L. Zimmern
Foundation for Genomics and Population Health
2 Worts Causeway
Cambridge, CBI 8RN (UK)
Tel. +44 122 374 0228, E-Mail email@example.com
The views expressed in this paper are those of the authors and do not reflect the opinions or positions of the Centers for Disease Control and Prevention.
Published online: April 4, 2012
Number of Print Pages : 7
Number of Figures : 1, Number of Tables : 3, Number of References : 33
Public Health Genomics
Vol. 15, No. 3-4, Year 2012 (Cover Date: April 2012)
Journal Editor: Brand A.M. (Maastricht)
ISSN: 1662-4246 (Print), eISSN: 1662-8063 (Online)
For additional information: http://www.karger.com/PHG